Sumitomo Dainippon Pharma Co Ltd - Gross Profit

Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Gross-Profit" stands at 253.56 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the highest value since 09/30/2023.

Sumitomo Dainippon Pharma Co Ltd's first quarter result of 63.89 Billion JPY for the item "Gross Profit" represents a decrease of -3.16 percent compared to it's fourth quarter result of the company's last fiscal year.

Also, Sumitomo Dainippon Pharma Co Ltd's first quarter result of 63.89 Billion JPY for the item "Gross Profit" represents an increase of 14.65 percent compared to it's first quarter result of last year.

Looking again at the trailing twelve months series (TTM), Sumitomo Dainippon Pharma Co Ltd's first quarter result of 253.56 Billion JPY for the item "Gross Profit" represents an increase of 3.33 percent compared to it's fourth quarter result of the company's last fiscal year.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 27.77 percent compared to the value the year prior.
The 1 year change in percent is 27.77.
The 3 year change in percent is -40.20.
The 5 year change in percent is -30.04.
The 10 year change in percent is -8.22.

The Serie's long term average value is 307.19 Billion Japanese Yens. It's latest available value, on 06/30/2025, is 17.46 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2024, to it's latest available value, on 06/30/2025, is +34.89%.
The Serie's change in percent from it's maximum value, on 06/30/2022, to it's latest available value, on 06/30/2025, is -40.20%.